AXSM

Mizuho Securities analyst Graig Suvannavejh maintained a Buy rating on Axsome Therapeutics (AXSM - Research Report) today and set a price target of $80.00. The company's shares opened today at $77.91.According to TipRanks, Suvannavejh is a 3-star analyst with an average return of 2.6% and a 54.10% success rate. Suvannavejh covers the Healthcare sector, focusing on stocks such as Axsome Therapeutics, Intra-Cellular Therapies, and Bioxcel Therapeutics.In addition to Mizuho Securities, Axsome Therapeutics also received a Buy from Guggenheim's Yatin Suneja in a report issued on November 28. However, on November 29, Morgan Stanley maintained a Hold rating on Axsome Therapeutics (NASDAQ: AXSM).
https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-their-buy-rating-for-axsome-therapeutics-axsm?utm_source=advfn.com&utm_medium=referral